[PDF][PDF] Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial

N Cağlar, I Dincer - Eur Rev Med Pharmacol Sci, 2011 - europeanreview.org
Aims: To compare the effects of nebivolol and ramipril on left ventricular hypertrophy in
hypertensive patients. Materials and Methods: The study was con-ducted with a pre …

Comparative Effects of a New Cardioselective Beta‐Blocker Nebivolol and Nifedipine Sustained‐Release on 24‐Hour Ambulatory Blood Pressure and Plasma …

Y Lacourcière, L Poirier, J Lefebvre… - The Journal of …, 1992 - Wiley Online Library
This double‐blind, parallel‐group study compared the effects of Nebivolol, a novel
cardioselective β‐blocker, with those of nifedipine sustained‐release on 24‐hour …

Nebivolol in the treatment of chronic heart failure

A Veverka, JL Salinas - Vascular health and risk management, 2007 - Taylor & Francis
Nebivolol is a highly selective beta1-adrenergic blocker that also enhances nitric oxide
bioavailability via the L-arginine-nitric oxide pathway, leading to vasodilation and decreased …

[HTML][HTML] Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension

VA Badar, SK Hiware, MP Shrivastava… - Indian journal of …, 2011 - journals.lww.com
Background: Nebivolol is a third-generation β-blocker, with highest β 1 selectivity and nitric-
oxide-derived vasodilatation. It also exhibits antiproliferative and antioxidant property that …

Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic Antagonist

A Van de Water, W Janssens… - Journal of …, 1988 - journals.lww.com
The pharmacological profile of nebivolol (N), a chemically novel β-adrenergic antagonist,
was assessed in investigations on isolated tissues, awake spontaneously hypertensive rats …

Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension

M Galderisi, A D'Errico, M Sidiropulos… - Journal of …, 2009 - journals.lww.com
Purpose Our aim was to analyze the effects of 3-month antihypertensive therapy by
nebivolol, a β-blocking agent with nitric oxide-mediated vasodilatory properties, on coronary …

[HTML][HTML] Therapeutic properties of highly selective β-blockers with or without additional vasodilator properties: focus on bisoprolol and nebivolol in patients with …

W AlHabeeb, S Mrabeti, AAI Abdelsalam - Cardiovascular Drugs and …, 2022 - Springer
Bisoprolol and nebivolol are highly selective β1-adrenoceptor antagonists, with clinical
indications in many countries within the management of heart failure with reduced left …

Realities of Newer β‐Blockers for the Management of Hypertension

C Manrique, TD Giles, KC Ferdinand… - The Journal of Clinical …, 2009 - Wiley Online Library
β‐blockers are prescribed for a variety of cardiovascular conditions including hypertension,
heart failure, primary treatment of myocardial infarction (MI), and secondary prevention of …

Animal pharmacology of nebivolol

WJ Janssens, R Xhonneux, PAJ Janssen - Drug Investigation, 1991 - Springer
Nebivolol is a mixture of equal amounts of 2 enantiomers: SR 3-nebivolol (d-nebivolol) and
RS 3-nebivolol (l-nebivolol). SR 3-nebivolol is a potent and selective β 1-adrenergic …

Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension

O Kamp, GT Sieswerda, CA Visser - The American journal of cardiology, 2003 - Elsevier
This was a double-blind, randomized, prospective study comparing the effects of nebivolol
and atenolol on systolic diastolic left ventricular function in patients with essential …